Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Exelixis, Inc. EXEL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
83/100
6/7 Pass
SharesGrow Intrinsic Value
$125.10
+182.5%
Analyst Price Target
$44.11
-0.4%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Exelixis, Inc. (EXEL), dont 14 achats et 28 ventes. Le total des achats d'initiés s'élève à $1.19M et le total des ventes d'initiés à $51.22M.

Les initiés notables ayant une activité récente comprennent Morrissey Michael, Senner Christopher J., Haley Patrick J.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — EXEL

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-02-26 Morrissey Michael President and CEO Attribution de RSU 160,437 - - 1,614,552
2026-02-26 Senner Christopher J. EVP and CFO Attribution de RSU 52,018 - - 1,028,110
2026-02-26 Haley Patrick J. EVP, Commercial Attribution de RSU 40,459 - - 422,367
2026-02-26 Aftab Dana EVP, Research and Development Attribution de RSU 52,018 - - 668,124
2026-02-26 Hefti Brenda SVP and General Counsel Attribution de RSU 23,119 - - 119,631
2026-02-24 Aftab Dana EVP, Research and Development Vente Informative 47,918 $44.50 $2.13M 616,106
2026-02-24 Morrissey Michael President and CEO Don (Donné) 100,278 - - 1,989,956
2026-02-19 Aftab Dana EVP, Research and Development Vente Informative 29,873 $44.35 $1.32M 664,024
2026-02-18 Morrissey Michael President and CEO Don (Donné) 125,094 - - 1,454,115
2026-02-18 Hefti Brenda SVP and General Counsel Vente Informative 18,669 $44.01 $821.62K 96,512
2026-02-18 Smith Julie Director Exercice d'Options (Vente) 44,087 $19.39 $854.85K -
2026-02-18 Wyszomierski Jack L Director Exercice d'Options (Vente) 20,634 $19.77 $407.93K -
2026-02-17 Morrissey Michael President and CEO Don (Donné) 250,736 - - 1,579,209
2026-02-17 Senner Christopher J. EVP and CFO Vente Informative 30,617 $43.67 $1.34M 976,092
2026-02-17 Haley Patrick J. EVP, Commercial Vente Informative 64,778 $43.50 $2.82M 381,908
2026-02-17 Smith Julie Director Exercice d'Options (Vente) 42,422 $18.19 $771.66K -
2026-02-15 Morrissey Michael President and CEO Retenue Fiscale RSU 120,390 $43.92 $5.29M 1,829,945
2026-02-15 Senner Christopher J. EVP and CFO Retenue Fiscale RSU 35,870 $43.92 $1.58M 1,006,709
2026-02-15 Haley Patrick J. EVP, Commercial Retenue Fiscale RSU 31,483 $43.92 $1.38M 449,722
2026-02-15 Aftab Dana EVP, Research and Development Retenue Fiscale RSU 12,720 $43.92 $558.66K 693,897
2026-02-15 Hefti Brenda SVP and General Counsel Retenue Fiscale RSU 5,430 $43.92 $238.49K 115,181
2026-02-13 Morrissey Michael President and CEO Exercice d'Options (Vente) 494,700 $21.31 $10.54M -
2026-02-13 Senner Christopher J. EVP and CFO Vente Informative 34,278 $43.00 $1.47M 1,042,579
2026-02-13 Oliver Bob Director Exercice d'Options (Vente) 9,088 $19.28 $175.22K 12,118
2026-02-13 Eckhardt Sue Gail Director Vente Informative 3,856 $43.79 $168.85K 17,524
2026-01-15 Morrissey Michael President and CEO Retenue Fiscale RSU 139,524 $45.23 $6.31M 1,825,241
2026-01-15 Senner Christopher J. EVP and CFO Retenue Fiscale RSU 40,459 $45.23 $1.83M 1,076,857
2026-01-15 Haley Patrick J. EVP, Commercial Retenue Fiscale RSU 32,332 $45.23 $1.46M 481,205
2026-01-15 Aftab Dana EVP, Research and Development Retenue Fiscale RSU 27,254 $45.23 $1.23M 733,102
2025-12-03 Hefti Brenda SVP and General Counsel Attribution de RSU 30,170 - - 120,611
2025-11-25 Johnson David Edward Director Achat Informatif 27,532 $43.12 $1.19M 1,553,262
2025-11-21 Haley Patrick J. EVP, Commercial Vente Informative 28,043 $42.58 $1.19M 374,029
2025-11-21 Aftab Dana EVP, Research and Development Don (Donné) 24,000 - - 640,778
2025-11-20 Haley Patrick J. EVP, Commercial Vente Informative 10,648 $41.77 $444.77K -
2025-11-17 Oliver Bob Director Don (Donné) 1,044 - - 42,282
2025-11-12 Morrissey Michael President and CEO Don (Donné) 101,548 - - 1,416,692
2025-11-12 Papadopoulos Stelios Director Vente Informative 100,000 $43.55 $4.36M 1,189,228
2025-11-11 Morrissey Michael President and CEO Don (Donné) 160,000 - - 1,692,856
2025-11-11 Beckerle Mary C Director Exercice d'Options (Vente) 5,784 $23.24 $134.42K 16,710
2025-11-11 Aftab Dana EVP, Research and Development Vente Informative 48,383 $42.50 $2.06M 664,778
2025-11-07 Hefti Brenda SVP and General Counsel Inconnu - - - 5,527
2025-10-08 Aftab Dana EVP, Research & Development Attribution de RSU 50,673 - - 713,161
2025-06-03 Wyszomierski Jack L Director Vente Informative 7,535 $43.09 $324.68K 358,882
2025-06-02 Eckhardt Sue Gail Director Vente Informative 4 $43.67 $174.68 21,380
2025-05-29 Wyszomierski Jack L Director Attribution de RSU 9,812 - - 366,417
2025-05-29 Poste George Director Attribution de RSU 9,812 - - 178,832
2025-05-29 Papadopoulos Stelios Director Attribution de RSU 9,812 - - 1,289,228
2025-05-29 Beckerle Mary C Director Attribution de RSU 9,812 - - 40,218
2025-05-29 Freire Maria C Director Attribution de RSU 9,812 - - 100,819
2025-05-29 Smith Julie Director Attribution de RSU 9,812 - - 20,590
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message